MYD88 and systemic lupus erythematosus: Here, active SLE patients showed the highest levels of MyD88 and NF-κB p65 in PBMC, followed by stable SLE patients, and then healthy participants (P < 0.05), suggesting a correlation between TLR9-MyD88-NF-κB p65 signal path and SLE.